51 results
Diabetes Pathophysiology and Medication Targets

The ominous octet is one concept that summarizes the different pathophysiologic pathways
Diabetes Pathophysiology ... and Medication ... used diabetes medications ... #Medication #Targets ... #Drug #Endocrinology
Hormonal Regulation of the Blood Calcium concentration

#Calcium #Regulation #Parathyroid #Calcitonin #Calcitriol #PTH #Endocrinology #Pathophysiology #Hormones
Regulation of the Blood ... Calcitriol #PTH #Endocrinology ... #Pathophysiology
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Common Diabetes Medications ... #Diabetes #Medications ... #pharmacology #pathophysiology ... #endocrinology
Dysmorphic Red Blood Cells on Electron Microscopy
This eyeSCANdy image shows dysmorphic red blood cells from the
Dysmorphic Red Blood ... Cells on Electron ... dysmorphic red blood ... pathology #hematology #nephrology
Hematuria in Post-Renal Transplant Patient
Prevalence up to 12% in the postrenal transplant patient
 • Bacterial: Escherichia
Prostate cancer • Medications ... Other: Chronic rejection ... diagnosis #kidney #blood ... management #treatment #nephrology
Menstrual Cycle Physiology: Ovarian Cycle – Brief Overview
LH and FSH are required for follicular development and
Follicular Phase - Selection ... #OvarianCycle #pathophysiology ... #menstruation #endocrinology
Pharmacological Treatment of Hepatorenal Syndrome (HRS)

Midodrine - Alpha agonist incr blood pressure incr renal perfusion pressure
Alpha agonist incr blood ... edgarvlermamd - Nephrology ... HepatoRenal #Syndrome #Nephrology ... #Pharmacology #Medications
Ischemic Stroke - Blood Pressure Management
 • No tPA  < 220 / 120 (permissive hypertension)
Ischemic Stroke - Blood ... Management #treatment #neurology ... #medications
Growth Hormone Excess - Pathogenesis and clinical findings
 • Acromegaly and gigantism share the same pathophysiology
share the same pathophysiology ... damage • decr eiection ... signs #symptoms #endocrinology ... #pathophysiology
Euglycemic Diabetic Ketoacidosis (EuDKA)
SGLT2 Inhibitors
Increasing Indications
Significant Adverse Drug Effects
Definition of EuDKA
 • Metabolic acidosis with pH
Inhibitors Increasing Indications ... Relatively low blood ... level < 200 mg/dL Pathophysiology ... diagnosis #management #endocrinology